ShareValue scores for 603669.SHG: Valuation 34, Quality 17, Growth 74, Health 54.
603669.SHGSSE
Lionco Pharm Grp Co Ltd
CN¥5.74
(+3.24%)
603669.SHGSSE
Lionco Pharm Grp Co Ltd
CN¥5.74(+3.24%)
Loading chart...
Sentiment
Verdicts
Value:Overvalued
Quality:Weak
Growth:Strong
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
-7% to 13%
Rating
Trap Risk
Return
-7% to 13%
Valuation
34
Overvalued
Price vs Value
Quality
17
Weak
Business Strength
Growth
74
Strong
Revenue & Earnings
Health
54
Moderate
Financial Stability
Momentum
76
Bullish
Price Trend
Company Details
About
Lionco Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products and medical services in China. It offers chemical and prescription drugs for nutrition, antimicrobial, antiviral, digestive, cardiovascular, cerebrovascular, detoxification, anti-tumor, and other applications. The company was founded in 2003 and is based in Shannan, China. Address: No. 20, National Highway 349, Shannan, China, 856100
Market Cap$4.05B
P/E RatioN/A
Dividend YieldNone
Sector Rank#1534
Score Analysis
AI Investment Thesis
Data as of:Jun 24, 2026
|Last calculated:Jun 24, 2026